Skip to main content
. 2021 Oct 14;22(6):832. doi: 10.3892/ol.2021.13093

Figure 1.

Figure 1.

Delphinidin inhibits the viability of the epidermal growth factor receptor-2-positive breast cancer cell lines. (A) MDA-MB-453 and BT-474 cells were treated with 10, 20, 40 or 80 µM delphinidin or DMSO. Relative cell numbers were determined using a Cell Counting Kit-8 assay after 48 h. #P<0.05 vs. control; ^P<0.05 vs. 20 µM; +P<0.05 vs. 40 µM; *P<0.05 vs. 80 µM. (B) The MDA-MB-453 and BT-474 cell lines were treated with 20, 40 and 80 µM delphinidin or DMSO. After 48 h, the cells were fixed, stained with H&E, then analyzed using a microscope (magnification, ×200). Experiments were repeated at least 3 times. DMSO, dimethyl sulfoxide.